25 related articles for article (PubMed ID: 38502805)
1. Antagonistic effects of the cytotoxic molecules granzyme B and TRAIL in the immunopathogenesis of sclerosing cholangitis.
Kellerer M; Javed S; Casar C; Will N; Berkhout LK; Schwinge D; Krebs CF; Schramm C; Neumann K; Tiegs G
Hepatology; 2024 Mar; ():. PubMed ID: 38441998
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
3. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B+ B cells detected by single-cell sequencing are associated with prognosis in patients with intrahepatic cholangiocarcinoma following liver transplantation.
Zhu JQ; Zhu Y; Qi M; Zeng Y; Liu ZJ; Ding C; Zhang T; Li XL; Han DD; He Q
Cancer Immunol Immunother; 2024 Feb; 73(3):58. PubMed ID: 38386050
[TBL] [Abstract][Full Text] [Related]
5. TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.
Tawfik D; Groth C; Gundlach JP; Peipp M; Kabelitz D; Becker T; Oberg HH; Trauzold A; Wesch D
Front Immunol; 2019; 10():2044. PubMed ID: 31555275
[TBL] [Abstract][Full Text] [Related]
6. Finding the TRAIL to escape granzyme B-mediated liver injury in PSC.
Guicciardi ME; Jalan-Sakrikar N
Hepatology; 2024 Mar; ():. PubMed ID: 38502805
[No Abstract] [Full Text] [Related]
7. Interaction Networks Converging on Immunosuppressive Roles of Granzyme B: Special Niches Within the Tumor Microenvironment.
Wang W; Zou R; Qiu Y; Liu J; Xin Y; He T; Qiu Z
Front Immunol; 2021; 12():670324. PubMed ID: 33868318
[TBL] [Abstract][Full Text] [Related]
8. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
Mazza S; Soro S; Verga MC; Elvo B; Ferretti F; Cereatti F; Drago A; Grassia R
World J Hepatol; 2021 Dec; 13(12):1828-1849. PubMed ID: 35069993
[TBL] [Abstract][Full Text] [Related]
9. Granzyme B as a therapeutic target for wound healing.
Turner CT; Hiroyasu S; Granville DJ
Expert Opin Ther Targets; 2019 Sep; 23(9):745-754. PubMed ID: 31461387
[No Abstract] [Full Text] [Related]
10. Liver transplant in primary sclerosing cholangitis: Current trends and future directions.
Shah YR; Nombera-Aznaran N; Guevara-Lazo D; Calderon-Martinez E; Tiwari A; Kanumilli S; Shah P; Pinnam BSM; Ali H; Dahiya DS
World J Hepatol; 2023 Aug; 15(8):939-953. PubMed ID: 37701917
[TBL] [Abstract][Full Text] [Related]
11. Granzyme B: a natural born killer.
Lord SJ; Rajotte RV; Korbutt GS; Bleackley RC
Immunol Rev; 2003 Jun; 193():31-8. PubMed ID: 12752668
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance.
Khan HA; Ahmad MZ; Khan JA; Arshad MI
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):245-256. PubMed ID: 28603092
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
